ロード中...
PPAR-γ Agonists As Antineoplastic Agents in Cancers with Dysregulated IGF Axis
It is now widely accepted that insulin resistance and compensatory hyperinsulinemia are associated to increased cancer incidence and mortality. Moreover, cancer development and progression as well as cancer resistance to traditional anticancer therapies are often linked to a deregulation/overactivat...
保存先:
| 出版年: | Front Endocrinol (Lausanne) |
|---|---|
| 主要な著者: | , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5319972/ https://ncbi.nlm.nih.gov/pubmed/28275367 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fendo.2017.00031 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|